Roles for miRNAs in endocrine resistance in breast cancer

Endocrine-related Cancer
Penn Muluhngwi, Carolyn M Klinge

Abstract

Therapies targeting estrogen receptor alpha (ERα), including selective ER modulators such as tamoxifen, selective ER downregulators such as fulvestrant (ICI 182 780), and aromatase inhibitors such as letrozole, are successfully used in treating breast cancer patients whose initial tumor expresses ERα. Unfortunately, the effectiveness of endocrine therapies is limited by acquired resistance. The role of microRNAs (miRNAs) in the progression of endocrine-resistant breast cancer is of keen interest in developing biomarkers and therapies to counter metastatic disease. This review focuses on miRNAs implicated as disruptors of antiestrogen therapies, their bona fide gene targets and associated pathways promoting endocrine resistance.

References

Jun 15, 1988·International Journal of Cancer. Journal International Du Cancer·G E FeichterK Goerttler
Oct 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M ClarkW L McGuire
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·R M LavinskyD W Rose
Jun 13, 1998·Journal of the National Cancer Institute·G A Colditz
Dec 7, 2000·Journal of the National Cancer Institute·R SchiffC K Osborne
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Oct 12, 2001·Apoptosis : an International Journal on Programmed Cell Death·S Mandlekar, A N Kong
Oct 19, 2001·Oncogene·J R Bradley, J S Pober
Nov 8, 2002·The Journal of Biological Chemistry·Mahnaz RazandiEllis R Levin
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Lan LiaoJianming Xu
Mar 26, 2003·Cell Death and Differentiation·H WajantP Scheurich
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lei LiJeffrey R Bender
May 21, 2003·Genes & Development·Gabriela DontuMax S Wicha
Oct 25, 2003·Oncogene·Robert ClarkeLeena A Hilakivi-Clarke
Feb 14, 2004·Molecular Endocrinology·Frank BarlettaBoris J Cheskis
Mar 23, 2004·Biochemical and Biophysical Research Communications·Filippo AcconciaMaria Marino
Apr 20, 2004·Cancer Cell·Darren M Brown, Erkki Ruoslahti
Jul 21, 2004·Molecular Cell·Gunter MeisterThomas Tuschl
Sep 15, 2004·Genome Research·Antony RodriguezAllan Bradley
Dec 3, 2004·Genes & Development·Jinju HanV Narry Kim
Dec 8, 2004·Endocrine Reviews·Matthew H Herynk, Suzanne A W Fuqua
Dec 23, 2004·Endocrine-related Cancer·Alistair Ring, Mitch Dowsett
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jun 18, 2005·Molecular Endocrinology·Stephanie SentisLaura Corbo
Jun 24, 2005·Nature·Thimmaiah P ChendrimadaRamin Shiekhattar
Jul 6, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Stephen R D JohnstonMitch Dowsett
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Aug 23, 2005·Vitamins and Hormones·Rebecca B RigginsRobert Clarke
Jun 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Zhaoyi WangThomas F Deuel
Aug 31, 2006·Molecular and Cellular Biology·Anwar HossainGrady F Saunders
May 29, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Erik A C Wiemer

❮ Previous
Next ❯

Citations

Dec 24, 2015·Frontiers in Medicine·Cristina Sorina CătanăIoana Berindan-Neagoe
Nov 26, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dong JiangYing Shan
Oct 29, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haibo LiuXiaopeng He
Aug 27, 2016·Clinical Breast Cancer·Angeles C Tecalco-Cruz, Josué O Ramírez-Jarquín
Mar 14, 2018·Endocrine-related Cancer·Tiago Vieira AugustoCristina Amaral
Feb 15, 2018·Endocrine-related Cancer·Carolyn M Klinge
May 20, 2016·Endocrine Reviews·Alessandro VillaAdriana Maggi
Mar 15, 2018·Oncotarget·Benjamin A FarberSanford M Simon
Nov 26, 2016·Bioscience Reports·Vijaya Narasihma Reddy GajulapalliBramanandam Manavathi
May 14, 2020·Cancers·Monica CantileGerardo Botti
Jul 14, 2017·Scientific Reports·Penn MuluhngwiCarolyn M Klinge
Aug 28, 2018·World Journal of Clinical Oncology·Angeles C Tecalco-Cruz, Josué O Ramírez-Jarquín
Jan 20, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yue YuXu-Chen Cao
Sep 10, 2019·Frontiers in Endocrinology·Md Moquitul Haque, Kartiki V Desai
Jun 25, 2020·Cancer Metastasis Reviews·Belinda J Petri, Carolyn M Klinge
Oct 2, 2019·Frontiers in Genetics·Maria AmorimCarmen Jerónimo
Dec 14, 2018·Frontiers in Immunology·Man WangKun Wang
Dec 29, 2020·International Journal of Radiation Biology·Zhi Xiong ChongWan Yong Ho
Mar 29, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiwei JiWilliam C Cho
Aug 28, 2021·Cancers·Angeliki AndrikopoulouFlora Zagouri
Oct 14, 2021·International Journal of Molecular Sciences·Matthew G DaveyMichael J Kerin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.